Huntington's Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
Condition: Huntington Disease Interventions: Drug: PTC518; Drug: Placebo Sponsor: PTC Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
Condition: Huntington Disease Interventions: Drug: SAGE-718; Drug: Placebo Sponsor: Sage Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
Condition: Huntington Disease Interventions: Drug: PTC518; Drug: Placebo Sponsor: PTC Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
Condition: Huntington Disease Interventions: Drug: SAGE-718; Drug: Placebo Sponsor: Sage Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
Condition: Huntington Disease Interventions: Drug: PTC518; Drug: Placebo Sponsor: PTC Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
Condition: Huntington Disease Interventions: Drug: SAGE-718; Drug: Placebo Sponsor: Sage Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
Condition: Huntington Disease Interventions: Drug: PTC518; Drug: Placebo Sponsor: PTC Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
Condition: Huntington Disease Intervention: Device: active tDCS Sponsor: The University of Texas Health Science Center, Houston Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2022 Category: Research Source Type: clinical trials
